AIB backs life science fund

✽ AIB has committed €15 million to a life science venture capital fund managed by

Fountain Healthcare Partners, with the latest investment bringing the total raised to

€103 million.

The fund, which launched in January, will primarily focus on specialty

pharmaceuticals, biotechnology, medical devices and diagnostics.

Ray Fitzpatrick, AIB’s head of equity investment unit, said that the bank

recognised “the value of venture capital funding to Irish companies”.

“The life sciences sector is ...